Efforts to pass federal drug pricing legislation, pronounced dead by many last week, arose in time for Halloween.
Liberal and conservative congressional Democrats and the White House reportedly are still trying to strike a deal centered on letting Medicare negotiate some drug prices and requiring drug manufacturers to pay the government rebates if prices of drugs reimbursed by Medicare rise faster than inflation. Last week, due to their failure to come together, Democrats removed all drug pricing language from their Build Back Better social, economic, and climate policy bill.
Efforts to pass federal drug pricing legislation, pronounced dead by many last week, arose in time for Halloween.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
